September 22, 2026 at 08:23 PM UTC
Vistagen Therapeutics, Inc. reports additional corporate update
Vistagen Therapeutics, Inc. filed an 8-K covering other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 22, 2026 at 08:22 PM UTC
Open official source